Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,5S,8S,11S,14S,17S)-1-((S)-2-((5R,8S,14S,17S,20S)-17-((1H-indol-3-yl)methyl)-1-amino-8-((R)-1-hydroxyethyl)-14-(hydroxymethyl)-5-(mercaptomethyl)-22-methyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazatricosan-20-ylcarbamoyl)pyrrolidin-1-yl)-5-(2-amino-2-oxoethyl)-17-((S)-2-((R)-2-((S)-2-aminopropanamido)-3-mercaptopropanamido)-3-hydroxypropanamido)-11-benzyl-8,14-bis(3-guanidinopropyl)-2-(mercaptomethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid
ID: ALA1240697
Chembl Id: CHEMBL1240697
PubChem CID: 52948030
Max Phase: Preclinical
Molecular Formula: C77H118N26O23S3
Molecular Weight: 1872.15
Molecule Type: Protein
Associated Items: